Empagliflozin CAS 864070-44-0: High-Purity API Supplier for Pharmaceutical R&D
Discover Empagliflozin, a key SGLT-2 inhibitor vital for type 2 diabetes management. We are a trusted manufacturer and supplier in China, providing high-purity Empagliflozin for your pharmaceutical R&D and manufacturing needs. Get a competitive price and reliable supply from NINGBO INNO PHARMCHEM CO.,LTD.
Get a Quote & SampleEmpagliflozin: Your Source for High-Quality Pharmaceutical Intermediates
Empagliflozin (CAS 864070-44-0)
As a leading chemical supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. offers Empagliflozin, a critical Active Pharmaceutical Ingredient (API) and intermediate used in the treatment of type 2 diabetes. We ensure the highest purity standards for our pharmaceutical clients, supporting your R&D and production cycles with consistent quality and supply stability.
- High Purity Empagliflozin: Sourced and manufactured to meet stringent pharmaceutical specifications, ensuring product efficacy.
- Trusted API Manufacturer: We are a reliable supplier for Empagliflozin, supporting global pharmaceutical companies.
- Competitive Pricing: Secure your supply of Empagliflozin at an advantageous price from our China-based manufacturing facilities.
- Efficient Supply Chain: Benefit from our robust logistics for timely delivery of Empagliflozin to your R&D or production sites.
Key Advantages of Sourcing Empagliflozin from NINGBO INNO PHARMCHEM CO.,LTD.
Consistent Quality Assurance
Our Empagliflozin (CAS 864070-44-0) consistently meets purity requirements, making it an ideal pharmaceutical intermediate for drug formulation. We provide detailed product specifications and COAs for your peace of mind.
Strategic Pharmaceutical Sourcing
As a dedicated supplier of pharmaceutical raw materials, we understand the importance of reliability. Purchasing Empagliflozin from us ensures a stable supply for your manufacturing operations.
Expertise in Chemical Manufacturing
Leverage our expertise as a manufacturer of advanced intermediates. Our production processes are optimized to deliver high-quality Empagliflozin efficiently, meeting the demands of the pharmaceutical industry.
Applications of Empagliflozin in Pharmaceutical Development
Type 2 Diabetes Treatment
Empagliflozin is a well-established SGLT-2 inhibitor used to improve glycemic control in adults with type 2 diabetes, making it a critical component for pharmaceutical manufacturers in this therapeutic area.
Cardiovascular Health
Research indicates Empagliflozin's benefits extend to cardiovascular health, offering significant potential for drug developers focusing on combined metabolic and cardiovascular therapies.
Active Pharmaceutical Ingredient (API)
This compound serves as a vital API, requiring strict adherence to quality and purity standards during its synthesis and supply chain management.
Pharmaceutical Intermediate
As a key intermediate, Empagliflozin is essential for the synthesis of various complex drug molecules, supporting innovation in pharmaceutical research and development.